Skip to main content

Table 1 Comparison of patients’ baseline information

From: Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-A study based on the MIMIC-IV database

HGI quartile

Q1 (<-0.77)

Q2(-0.77, -0.37)

Q3(-0.37, 0.25)

Q4 (> 0.25)

P-value

N

1315

1314

1316

1315

 

Age (years)

70.85 (62.11–78.83)

70.49 (62.26–78.35)

72.32 (64.32–79.85)

68.17 (60.70–76.13)

< 0.001

Gender (%)

    

< 0.001

Male

957 (72.78%)

989 (75.27%)

906 (68.84%)

896 (68.14%)

 

Female

358 (27.22%)

3\5 (24.73%)

410 (31.16%)

419 (31.86%)

 

BMI (kg/m2)

28.16(25.03–31.59)

28.19 (25.26–31.19)

28.54 (25.26–31.96)

29.58 (26.54–33.15)

< 0.001

CABG (%)

    

0.025

No

1203 (91.48%)

1218 (92.69%)

1197 (90.96%)

1175 (89.35%)

 

Yes

112 (8.52%)

96 (7.31%)

119 (9.04%)

140 (10.65%)

 

PTCA (%)

    

0.060

No

1070 (81.37%)

1065 (81.05%)

1047 (79.56%)

1020 (77.57%)

 

Yes

245 (18.63%)

249 (18.95%)

269 (20.44%)

295 (22.43%)

 

AMI (%)

    

< 0.001

No

892 (67.83%)

1000 (76.10%)

1048 (79.64%)

981 (74.60%)

 

Yes

423 (32.17%)

314 (23.90%)

268 (20.36%)

334 (25.40%)

 

AHF (%)

    

< 0.001

No

1004 (76.35%)

1102 (83.87%)

1059 (80.47%)

1024 (77.87%)

 

Yes

311 (23.65%)

212 (16.13%)

257 (19.53%)

291 (22.13%)

 

AF (%)

    

< 0.001

No

776 (59.01%)

816 (62.10%)

760 (57.75%)

886 (67.38%)

 

Yes

539 (40.99%)

498 (37.90%)

556 (42.25%)

429 (32.62%)

 

Hypertension (%)

    

< 0.001

No

678 (51.56%)

565 (43.00%)

566 (43.01%)

652 (49.58%)

 

Yes

637 (48.44%)

749 (57.00%)

750 (56.99%)

663 (50.42%)

 

Diabetes (%)

    

< 0.001

No

971 (73.84%)

1026 (78.08%)

763 (57.98%)

114 (8.67%)

 

Yes

344 (26.16%)

288 (21.92%)

553 (42.02%)

1201 (91.33%)

 

CKD5 (%)

    

< 0.001

No

1242 (94.45%)

1289 (98.10%)

1287 (97.80%)

1276 (97.03%)

 

Yes

73 (5.55%)

25 (1.90%)

29 (2.20%)

39 (2.97%)

 

Invasive ventilation (%)

    

0.224

No

353 (26.84%)

314 (23.90%)

331 (25.15%)

354 (26.92%)

 

Yes

962 (73.16%)

1000 (76.10%)

985 (74.85%)

961 (73.08%)

 

Blood lipid regulation (%)

    

< 0.001

No

130 (9.89%)

78 (5.94%)

82 (6.23%)

78 (5.93%)

 

Yes

1185 (90.11%)

1236 (94.06%)

1234 (93.77%)

1237 (94.07%)

 

Antiplatelet (%)

    

0.163

No

61 (4.64%)

39 (2.97%)

44 (3.34%)

49 (3.73%)

 

Single antiplatelet

914 (69.51%)

923 (70.24%)

918 (69.76%)

884 (67.22%)

 

Double antiplatelet

340 (25.86%)

352 (26.79%)

354 (26.90%)

382 (29.05%)

 

ACEI/ARB (%)

    

< 0.001

No

688 (52.32%)

634 (48.25%)

547 (41.57%)

499 (37.95%)

 

Yes

627 (47.68%)

680 (51.75%)

769 (58.43%)

816 (62.05%)

 

β-blockers (%)

    

0.003

No

146 (11.10%)

107 (8.14%)

108 (8.21%)

150 (11.41%)

 

Yes

1169 (88.90%)

1207 (91.86%)

1208 (91.79%)

1165 (88.59%)

 

Insulin (%)

    

< 0.001

No

491 (37.34%)

528 (40.18%)

445 (33.81%)

100 (7.60%)

 

Yes

824 (62.66%)

786 (59.82%)

871 (66.19%)

1215 (92.40%)

 

SOFA

5.00 (3.00–7.00)

4.00 (2.00–6.00)

4.00 (2.00–7.00)

5.00 (3.00–7.00)

< 0.001

APSIII

37.00 (27.50–53.00)

34.00 (26.00-45.75)

35.00 (28.00–47.00)

40.00 (31.00–51.00)

< 0.001

WBC (×109/L)

9.50 (7.00-13.30)

9.10 (7.00–12.13)

9.20 (7.00–12.10)

9.50 (7.40–12.50)

0.005

RBC (×109/L)

3.94 (3.24–4.46)

3.99 (3.35–4.50)

3.99 (3.37–4.48)

3.93 (3.33–4.50)

0.131

PLT (×109/L)

193.00 (155.00-245.00)

202.00 (159.00-245.00)

201.00 (161.00-245.92)

206.00 (161.00-261.00)

0.001

HGB (g/L)

12.00 (9.90–13.70)

12.18 (10.20–13.80)

11.90 (10.00–13.40)

11.40 (9.80–13.30)

< 0.001

blood creatinine (mg/dL)

1.00 (0.80–1.40)

1.00 (0.80–1.20)

1.00 (0.80–1.30)

1.10 (0.90–1.40)

< 0.001

FPG (mg/dL)

131.00 (109.00–168.00)

109.00 (98.00–127.80)

109.00 (97.00–134.00)

142.00 (106.00–182.00)

< 0.001

  1. Continuous numerical variables are expressed as medians (interquartile spacing) and categorical variables are expressed as numbers (percentages)
  2. CABG: coronary artery bypass grafting, PTCA: Percutaneous transluminal coronary angioplasty, AMI: acute myocardial infarction, AHF: acute heart failure, AF: atrial fibrillation, CKD5: chronic kidney disease stage 5, ACEI: angiotensin-converting enzyme inhibition, ARB: angiotensin receptor blocker, SOFA: Sepsis-Organ Failure Assessment Score, APSIII: Acute Physiology Score III, WBC: white blood cells, RBC: red blood cells, PLT: platelets, HGB: hemoglobin, FPG: fasting plasma glucose
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840